Structural and functional correlations of skin barrier in health and disease: Models and evaluation

Toxicology of the Skin

Volumn , Issue , 2010, Pages 110-130

  Menon, Gopinathan K ^a   Fartasch, Manigé ^b  

^a ISP Corporation   (United States)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861764559     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (125)

1. Elias PM, Feingold KR. Permeability barrier homeostasis. In: Elias PM, Feingold KR, eds. Skin Barrier. New York, London: Taylor Francis, 2006.
2. Hoath S. The skin as a neurodevelopmental interface. Neo Rev 2001; 2:269-281.
3. Menon GK. Caveolins in epidermal lamellar bodies: skin is an interactive interface, not an inflexible barrier. J Invest Dermatol 2003; 120(4):15-16.
4. Tobin DJ. Biochemistry of human skin—our brain on the outside. Chem Soc Rev 2006; 35(1):52-67.
5. Elias PM, Choi EH. Interactions among stratum corneum defensive functions. Exp Dermatol 2005; 14(10):719-726.
6. Elias PM, Brown BE. The mammalian cutaneous permeability barrier: defective barrier function is essential fatty acid deficiency correlates with abnormal intercellular lipid deposition. Lab Invest 1978; 39(6):574-583.
7. Landmann L. The epidermal permeability barrier. Anat Embryol (Berl) 1988; 178(1): 1-13.
8. Scheuplein RJ, Blank IH. Permeability of the skin. Physiol Rev 1971; 51(4):702-747.
9. Evans CL, Potma EO, Puoris’haag M, et al. Chemical imaging of tissue in vivo with video-rate coherent anti-Stokes Raman scattering microscopy. Proc Natl Acad Sci U S A 2005; 102(46):16807-16812.
10. Elias PM, Friend DS. The permeability barrier in mammalian epidermis. J Cell Biol 1975; 65(1):180-191.
11. Hou SY, Mitra AK, White SH, et al. Membrane structures in normal and essential fatty acid-deficient stratum corneum: characterization by ruthenium tetroxide staining and x-ray diffraction. J Invest Dermatol 1991; 96(2):215-223.
12. Madison KC, Swartzendruber DC, Wertz PW, et al. Presence of intact intercellular lipid lamellae in the upper layers of the stratum corneum. J Invest Dermatol 1987; 88(6):714-718.
13. Bouwstra JA, Ponec M. The skin barrier in healthy and diseased state. Biochim Biophys Acta 2006; 1758(12):2080-2095.
14. Elias PM, Williams ML, Maloney ME, et al. Stratum corneum lipids in disorders of cornification. Steroid sulfatase and cholesterol sulfate in normal desquamation and the pathogenesis of recessive X-linked ichthyosis. J Clin Invest 1984; 74(4):1414-1421.
15. Feingold KR. Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res 2007; 48(12):2531-2546.
16. Holleran WM, Takagi Y, Menon GK, et al. Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. J Clin Invest 1993; 91(4):1656-1664.
17. Madison KC. Barrier function of the skin: “la raison d’etre” of the epidermis. J Invest Dermatol 2003; 121(2):231-241.
18. Mao-Qiang M, Feingold KR, Jain M, et al. Extracellular processing of phospholipids is required for permeability barrier homeostasis. J Lipid Res 1995; 36(9):1925-1935.
19. Menon GK, Grayson S, Elias PM. Cytochemical and biochemical localization of lipase and sphingomyelinase activity in mammalian epidermis. J Invest Dermatol 1986; 86(5):591-597.
20. Wertz PW. Lipids and barrier function of the skin. Acta Derm Venereol Suppl (Stockh) 2000; 208:7-11.
21. Holleran WM, Ginns EI, Menon GK, et al. Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease. J Clin Invest 1994; 93(4):1756-1764.
22. Miyazaki M, Dobrzyn A, Elias PM, et al. Stearoyl-CoA desaturase-2 gene expression is required for lipid synthesis during early skin and liver development. Proc Natl Acad Sci U S A 2005; 102(35):12501-12506.
23. Cameron DJ, Tong Z, Yang Z, et al. Essential role of Elovl4 in very long chain fatty acid synthesis, skin permeability barrier function, and neonatal survival. Int J Biol Sci 2007; 3(2):111-119.
24. Li W, Sandhoff R, Kono M, et al. Depletion of ceramides with very long chain fatty acids causes defective skin permeability barrier function, and neonatal lethality in ELOVL4 deficient mice. Int J Biol Sci 2007; 3(2):120-128.
25. Milstone LM. Epidermal desquamation. J Dermatol Sci 2004; 36(3):131-140.
26. Oren A, Ganz T, Liu L, et al. In human epidermis, beta-defensin 2 is packaged in lamellar bodies. Exp Mol Pathol 2003; 74(2):180-182.
27. Braff MH, Bardan A, Nizet V, et al. Cutaneous defense mechanisms by antimicrobial peptides. J Invest Dermatol 2005; 125(1):9-13.
28. Grayson S, Johnson-Winegar AG, Wintroub BU, et al. Lamellar body-enriched fractions from neonatal mice: preparative techniques and partial characterization. J Invest Dermatol 1985; 85(4):289-294.
29. Freinkel RK, Traczyk TN. Lipid composition and acid hydrolase content of lamellar granules of fetal rat epidermis. J Invest Dermatol 1985; 85(4):295-298.
30. Elias PM, Cullander C, Mauro T, et al. The secretory granular cell: the outermost granular cell as a specialized secretory cell. J Investig Dermatol Symp Proc 1998; 3(2):87-100.
31. Menon GK, Ghadially R. Morphology of lipid alterations in the epidermis: a review. Microsc Res Tech 1997; 37(3):180-192.
32. Fartasch M, Diepgen TL, Hornstein OP. Atopic dermatitis—ichthyosis vulgaris— hyperlinear palms—an ultrastructural study. Dermatologica 1989; 178(4):202-205.
33. Fartasch M, Bassukas ID, Diepgen TL. Disturbed extruding mechanism of lamellar bodies in dry non-eczematous skin of atopics. Br J Dermatol 1992; 127(3):221-227.
34. Fartasch M, Williams ML, Elias PM. Altered lamellar body secretion and stratum corneum membrane structure in Netherton syndrome: differentiation from other infantile erythrodermas and pathogenic implications. Arch Dermatol 1999; 135(7): 823-832.
35. Fartasch M. The epidermal lamellar body: a fascinating secretory organelle. J Invest Dermatol 2004; 122(5):11-12.
36. Menon GK, Ghadially R, Williams ML, et al. Lamellar bodies as delivery systems of hydrolytic enzymes: implications for normal and abnormal desquamation. Br J Dermatol 1992; 126(4):337-345.
37. Schmuth M, Yosipovitch G, Williams ML, et al. Pathogenesis of the permeability barrier abnormality in epidermolytic hyperkeratosis. J Invest Dermatol 2001; 117(4): 837-847.
38. Hachem JP, Crumrine D, Fluhr J, et al. pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 2003; 121(2):345-353.
39. Mauro TM. SC pH: measurement, origins, and functions. In: Elias PM, Feingold KR, eds. Skin Barrier. New York, London: Taylor Francis, 2006.
40. Raymond AA, Gonzalez de PA, Stella A, et al. Lamellar bodies of human epidermis: proteomics characterization by high throughput mass spectrometry and possible involvement of CLIP-170 in their trafficking/secretion. Mol Cell Proteomics 2008; 7(11):2151-2175.
41. Ishida-Yamamoto A, Kishibe M, Takahashi H, et al. Rab11 is associated with epidermal lamellar granules. J Invest Dermatol 2007; 127(9):2166-2170.
42. Liu L, Roberts AA, Ganz T. By IL-1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. J Immunol 2003; 170(1):575-580.
43. Holleran WM, Takagi Y, Uchida Y. Epidermal sphingolipids: metabolism, function, and roles in skin disorders. FEBS Lett 2006; 580(23):5456-5466.
44. Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol 2008; 17(12):1063-1072.
45. Brandner JM, Proksch E. Epidermal barrier function: role of tight junctions. In: Elias PM, Feingold KR, eds. Skin Barrier. New York: Marcel Dekker Inc., 2006.
46. Denda M, Tsuchiya T, Elias PM, et al. Stress alters cutaneous permeability barrier homeostasis. Am J Physiol Regul Integr Comp Physiol 2000; 278(2):R367-R372.
47. Kleyn CE, Schneider L, Saraceno R, et al. The effects of acute social stress on epidermal Langerhans’ cell frequency and expression of cutaneous neuropeptides. J Invest Dermatol 2008; 128(5):1273-1279.
48. Menon GK, Menon J. Avian epidermal lipids: functional considerations and relationship to feathering. Am Zool 2000; 40:540-552.
49. Menon GK, Elias P. The epidermal barrier and strategies for surmounting it: an overview. In: Hengge U, Volc-Platzer B, eds. The Skin and Gene Therapy. Heidelberg: Springer-Verlag, 2001.
50. Segre JA. Epidermal differentiation complex yields a secret: mutations in the cornification protein filaggrin underlie ichthyosis vulgaris. J Invest Dermatol 2006; 126(6):1202-1204.
51. Segre J. Complex redundancy to build a simple epidermal permeability barrier. Curr Opin Cell Biol 2003; 15(6):776-782.
52. Roop D. Defects in the barrier. Science 1995; 267(5197):474-475.
53. Fuchs E, Coulombe PA. Of mice and men: genetic skin diseases of keratin. Cell 1992; 69(6):899-902.
54. Fartasch M. Human barrier formation and reaction to irritation. In: Elsner P, Maibach HI, eds. Irritant Dermatitis. New Clinical and Experimental Aspects. 23rd ed. Basel, Schweiz: Karger, 1995:95-103.
55. Jacobs JJ, Lehe CL, Hasegawa H, et al. Das PK. Skin irritants and contact sensitizers induce Langerhans cell migration and maturation at irritant concentration. Exp Dermatol 2006; 15(6):432-440.
56. Uter W, Schnuch A, Geier J, et al. Epidemiology of contact dermatitis. The information network of departments of dermatology (IVDK) in Germany. Eur J Dermatol 1998; 8(1):36-40.
57. Agner T, Johansen JD, Overgaard L, et al. Combined effects of irritants and allergens. Synergistic effects of nickel and sodium lauryl sulfate in nickel-sensitized individuals. Contact Dermatitis 2002; 47(1):21-26.
58. Bonneville M, Chavagnac C, Vocanson M, et al. Skin contact irritation conditions the development and severity of allergic contact dermatitis. J Invest Dermatol 2007; 127(6):1430-1435.
59. Brasch J, Burgard J, Sterry W. Common pathogenetic pathways in allergic and irritant contact dermatitis. J Invest Dermatol 1992; 98(2):166-170.
60. Grabbe S, Steinert M, Mahnke K, et al. Dissection of antigenic and irritative effects of epicutaneously applied haptens in mice. Evidence that not the antigenic component but nonspecific proinflammatory effects of haptens determine the concentrationdependent elicitation of allergic contact dermatitis. J Clin Invest 1996; 98(5):1158-1164.
61. McLelland J, Shuster S, Matthews JN. ‘Irritants’ increase the response to an allergen in allergic contact dermatitis. Arch Dermatol 1991; 127(7):1016-1019.
62. Pedersen LK, Johansen JD, Held E, et al. Augmentation of skin response by exposure to a combination of allergens and irritants—a review. Contact Dermatitis 2004; 50(5):265-273.
63. Basketter DA, Kan-King-Yu D, Dierkes P, et al. Does irritation potency contribute to the skin sensitization potency of contact allergens? Cutan Ocul Toxicol 2007; 26(4): 279-286.
64. Kimber I, Dearman RJ, Gerberick GF, et al. Designation of substances as skin sensitizing chemicals: a commentary. Hum Exp Toxicol 2003; 22(8):439-443.
65. Saint-Mezard P, Rosieres A, Krasteva M, et al. Allergic contact dermatitis. Eur J Dermatol 2004; 14(5):284-295.
66. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999; 5(11):1249-1255.
67. McFadden JP, Basketter DA. Contact allergy, irritancy and ‘danger’. Contact Dermatitis 2000; 42(3):123-127.
68. Callard RE, Harper JI. The skin barrier, atopic dermatitis and allergy: a role for Langerhans cells? Trends Immunol 2007; 28(7):294-298.
69. Hudson TJ. Skin barrier function and allergic risk. Nat Genet 2006; 38(4):399-400.
70. Willis CM, Stephens CJ, Wilkinson JD. Selective expression of immune-associated surface antigens by keratinocytes in irritant contact dermatitis. J Invest Dermatol 1991; 96(4):505-511.
71. Nickoloff BJ, Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 1994; 30(4):535-546.
72. Tsai JC, Feingold KR, Crumrine D, et al. Permeability barrier disruption alters the localization and expression of TNF alpha/protein in the epidermis. Arch Dermatol Res 1994; 286(5):242-248.
73. Wilmer JL, Burleson FG, Kayama F, et al. Cytokine induction in human epidermalkeratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin. J Investig Dermatol 1994; 102(6):915-922.
74. Wood LC, Jackson SM, Elias PM, et al. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 1992; 90(2):482-487.
75. von den Driesch P, Fartasch M, Huner A, et al. Expression of integrin receptors and ICAM-1 on keratinocytes in vivo and in an in vitro reconstructed epidermis: effect of sodium dodecyl sulphate. Arch Dermatol Res 1995; 287(3-4):249-253.
76. Lindberg M, Forslind B, Sagstrom S, et al. Elemental changes in guinea pig epidermis at repeated exposure to sodium lauryl sulfate. Acta Derm Venereol 1992; 72(6):428-431.
77. Prottey C, Hartop PJ. Changes in glycerolipid metabolism in rat epidermis following exaggerated washing with soap solutions. J Invest Dermatol 1973; 61(3):168-179.
78. Nakamura M, Rikimaru T, Yano T, et al. Full-thickness human skin explants for testing the toxicity of topically applied chemicals. J Invest Dermatol 1990; 95(3): 325-332.
79. Tovell PW, Weaver AC, Hope J, et al. The action of sodium lauryl sulphate on rat skin-an ultrastructural study. Br J Dermatol 1974; 90(5):501-506.
80. Fartasch M. Ultrastructure of the epidermal barrier after irritation. Microsc Res Tech 1997; 37(3):193-199.
81. Fartasch M, Schnetz E, Diepgen TL. Characterization of detergent-induced barrier alterations—effect of barrier cream on irritation. J Investig Dermatol Symp Proc 1998; 3(2):121-127.
82. Fluhr JW, Akengin A, Bornkessel A, et al. Additive impairment of the barrier function by mechanical irritation, occlusion and sodium lauryl sulphate in vivo. Br J Dermatol 2005; 153(1):125-131.
83. Lee JN, Jee SH, Chan CC, et al. The effects of depilatory agents as penetration enhancers on human stratum corneum structures. J Invest Dermatol 2008; 128(9): 2240-2247.
84. Menon GK, Feingold KR, Elias PM. Lamellar body secretory response to barrier disruption. J Invest Dermatol 1992; 98(3):279-289.
85. Menon GK, Elias PM, Feingold KR. Integrity of the permeability barrier is crucial for maintenance of the epidermal calcium gradient. Br J Dermatol 1994; 130(2):139-147.
86. Lupulescu AP, Birmingham DJ, Pinkus H. An electron microscopic study of human epidermis after acetone and kerosene administration. J Invest Dermatol 1973; 60(1): 33-45.
87. Ghadially R, Halkier-Sorensen L, Elias PM. Effects of petrolatum on stratum corneum structure and function. J Am Acad Dermatol 1992; 26(3 pt 2):387-396.
88. Man MQ, Feingold KR, Elias PM. Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin. Arch Dermatol 1993; 129(6):728-738.
89. Fartasch M, Bassukas ID, Diepgen TL. Structural relationship between epidermal lipid lamellae, lamellar bodies and desmosomes in human epidermis: an ultrastructural study. Br J Dermatol 1993; 128(1):1-9.
90. Fartasch M, Ponec M. Improved barrier structure formation in air-exposed human keratinocyte culture systems. J Invest Dermatol 1994; 102(3):366-374.
91. Bauer J, Bahmer FA, Worl J, et al. A strikingly constant ratio exists between Langerhans cells and other epidermal cells in human skin. A stereologic study using the optical disector method and the confocal laser scanning microscope. J Invest Dermatol 2001; 116(2):313-318.
92. Chavanas S, Bodemer C, Rochat A, et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 2000; 25(2):141-142.
93. Imokawa G, Abe A, Jin K, et al. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 1991; 96(4):523-526.
94. Melnik B, Hollmann J, Hofmann U, et al. Lipid composition of outer stratum corneum and nails in atopic and control subjects. Arch Dermatol Res 1990; 282(8): 549-551.
95. Schafer L, Kragballe K. Abnormalities in epidermal lipid metabolism in patients with atopic dermatitis. J Invest Dermatol 1991; 96(1):10-15.
96. Yamamoto A, Serizawa S, Ito M, et al. Stratum corneum lipid abnormalities in atopic dermatitis. Arch Dermatol Res 1991; 283(4):219-223.
97. Jensen JM, Folster-Holst R, Baranowsky A, et al. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 2004; 122(6):1423-1431.
98. Proksch E, Elias PM, Feingold KR. Regulation of 3-hydroxy-3-methylglutarylcoenzyme A reductase activity in murine epidermis. Modulation of enzyme content and activation state by barrier requirements. J Clin Invest 1990; 85(3):874-882.
99. Bleck O, Abeck D, Ring J, et al. Two ceramide subfractions detectable in Cer (AS) position by HPTLC in skin surface lipids of non-lesional skin of atopic eczema. J Invest Dermatol 1999; 113(6):894-900.
100. Murahata M, Crowe DM, Roheim JR. The use of transepidermal water loss to measure and predict the irritation response to surfactants. Int J Cosmet Sci 1986; 8:225-229.
101. Ohnishi Y, Okino N, Ito M, et al. Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis. Clin Diagn Lab Immunol 1999; 6(1):101-104.
102. Elias PM, Feingold KR, Fartasch M. The epidermal lamellar body as a multifunctional secretory organelle. In: Elias PM, Feingold KR, eds. Skin Barrier. New York: Marcel Dekker, 2005.
103. Fartasch M, Deters A, Schnetz E, et al. Cutaneous penetration: its modulation by skin care products. Contact Dermatitis 2006:55.
104. Pilgram GS, Vissers DC, van der Meulen H, et al. Aberrant lipid organization in stratum corneum of patients with atopic dermatitis and lamellar ichthyosis. J Invest Dermatol 2001; 117(3):710-717.
105. Jakasa I, de Jongh CM, Verberk MM, et al. Percutaneous penetration of sodium lauryl sulphate is increased in uninvolved skin of patients with atopic dermatitis compared with control subjects. Br J Dermatol 2006; 155(1):104-109.
106. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38(4):441-446.
107. Novak N, Baurecht H, Schafer T, et al. Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol 2008; 128(6): 1430-1435.
108. Kezic S. Methods for measuring in-vivo percutaneous absorption in humans. Hum Exp Toxicol 2008; 27(4):289-295.
109. Lerbaek A, Bisgaard H, Agner T, et al. Filaggrin null alleles are not associated with hand eczema or contact allergy. Br J Dermatol 2007; 157(6):1199-1204.
110. Denda M, Fuziwara S. Visible radiation affects epidermal permeability barrier recovery: selective effects of red and blue light. J Invest Dermatol 2008; 128(5):1335-1336.
111. Sabolinski ML, Alvarez O, Auletta M, et al. Cultured skin as a ’smart material’ for healing wounds: experience in venous ulcers. Biomaterials 1996; 17(3):311-320.
112. Tu MC, Lillywhite HB, Menon JG, et al. Postnatal ecdysis establishes the permeability barrier in snake skin: new insights into barrier lipid structures. J Exp Biol 2002; 205(pt 19):3019-3030.
113. Denda M, Sato J, Masuda Y, et al. Exposure to a dry environment enhances epidermal permeability barrier function. J Invest Dermatol 1998; 111(5):858-863.
114. Denda M, Sokabe T, Fukumi-Tominaga T, et al. Effects of skin surface temperature on epidermal permeability barrier homeostasis. J Invest Dermatol 2007; 127(3): 654-659.
115. Boutin AT, Weidemann A, Fu Z, et al. Epidermal sensing of oxygen is essential for systemic hypoxic response. Cell 2008; 133(2):223-234.
116. Stucker M, Struk A, Altmeyer P, et al. The cutaneous uptake of atmospheric oxygen contributes significantly to the oxygen supply of human dermis and epidermis. J Physiol 2002; 538(pt 3):985-994.
117. Minson CT. Hypoxic regulation of blood flow in humans. Skin blood flow and temperature regulation. Adv Exp Med Biol 2003; 543:249-262.
118. Mauro T, Bench G, Sidderas-Haddad E, et al. Acute barrier perturbation abolishes the Ca2+ and K+ gradients in murine epidermis: quantitative measurement using PIXE. J Invest Dermatol 1998; 111(6):1198-1201.
119. Charles RP, Guitard M, Leyvraz C, et al. Postnatal requirement of the epithelial sodium channel for maintenance of epidermal barrier function. J Biol Chem 2008; 283(5):2622-2630.
120. Cai T, Wang H, Chen Y, et al. Regulation of caveolin-1 membrane trafficking by the Na/K-ATPase. J Cell Biol 2008; 182(6):1153-1169.
121. Sando GN, Zhu H, Weis JM, et al. Caveolin expression and localization in human keratinocytes suggest a role in lamellar granule biogenesis. J Invest Dermatol 2003; 120(4):531-541.
122. Reed JT, Ghadially R, Elias PM. Skin type, but neither race nor gender, influence epidermal permeability barrier function. Arch Dermatol 1995; 131(10):1134-1138.
123. Menon GK. New insights into skin structure: scratching the surface. Adv Drug Deliv Rev 2002; 54(suppl 1):S3-S17.
124. Vicanova J, Mommaas AM, Mulder AA, et al. Impaired desquamation in the in vitro reconstructed human epidermis. Cell Tissue Res 1996; 286(1):115-122.
125. Warner RR, Boissy YL, Lilly NA, et al. Water disrupts stratum corneum lipid lamellae: damage is similar to surfactants. J Invest Dermatol 1999; 113(6):960-966.